Proteomic and genetic approaches identify Syk as an AML target
Hahn, C. K., J. E. Berchuck, K. N. Ross, R. M. Kakoza, K. Clauser, A. C. Schinzel, L. Ross, et al. 2009. “Proteomic and Genetic Approaches Identify Syk As an AML Target”. Cancer Cell 16: 281-94.